Takeda CSO Chris Arendt on Transforming Drug Discovery & the R&D Pipeline
Podcasts
•
18m
Takeda is entering one of the most pivotal moments in its 245-year history, with a late-stage pipeline poised to transform patient outcomes across three therapeutic areas. Chief Scientific Officer Chris Arendt goes Inside the ICE House to discuss the science behind drug candidates targeting narcolepsy, polycythemia vera, and psoriasis. He explores how AI and computational technologies are reshaping drug discovery and why building the right data foundation is critical to supercharging Takeda's R&D engine.
Up Next in Podcasts
-
James Rutledge Shares Six Decades of ...
Longtime New York Stock Exchange member and former Director James Rutledge goes Inside the ICE House to reflect on a remarkable career that began with a help wanted sign on Wall Street in 1968. He shares firsthand stories from the paperwork crisis, the transition from pneumatic tubes and paper ti...
-
Rubrik's Cal Al-Dhubaib on Securing A...
Rubrik Principal Technologist Cal Al-Dhubaib joins Inside the ICE House to discuss how enterprises can securely adopt AI as autonomous agents gain greater access to data, systems, and code. He explains how Rubrik Agent Cloud helps organizations monitor AI activity, govern agent behavior, and reco...
-
Inside the ICE House x Las Vegas: Des...
From Lake Las Vegas, Nevada, Nancy Paton, award-winning filmmaker and founder of Desert Rose Films, goes Inside the ICE House to discuss why authentic storytelling is becoming essential for companies looking to connect with audiences. She explains how long-term trust, consistency, and meaningful ...
